🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tianxiong Mi

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0003-4014-4060
Biochemistry, Genetics and Molecular BiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye disease.

20 citations

Shaon Joy, Tianxiong Mi, Ghasem Yazdanpanah, Kevin Burgess, Cintia S. de Paiva +1 more

8 citations

Duyen Thi Cam Nguyen, Kevin Burgess, Tianxiong Mi

N/A
0DataRank · unranked
6 citations

Siriwalee Siriwibool, Kevin Burgess, Tianxiong Mi

0 citations

Siriwalee Siriwibool, Kevin Burgess, Tianxiong Mi

4 citations

Duyen Nguyen, Zhe Gao, Kevin Burgess, Tianxiong Mi

Dual-Capped Helical Interface Mimics

Journal of the American Chemical Society(2024)10.1021/jacs.3c11717
N/A
0DataRank · unranked
3 citations

Zhe Gao, Zeynep Mituta, Kevin Burgess, Tianxiong Mi

2 citations

Tianxiong Mi, Rui-Liang Lyu, Thitima Pewklang, Tye Thompson, Arthur Sefiani +3 more

4 citations

Kevin Burgess, Tianxiong Mi

N/A
0DataRank · unranked
0 citations

Lorenz Mattes, Thitima Pewklang, Karin Hauser, Kevin Burgess, Tianxiong Mi